Xana Smart Neurostimulation

Health Care, Health Diagnostics, Medical, Medical Device, Wellness
Founded in 2016-01-01
Epalinges, Vaud, Switzerland
For Profit

About Xana Smart Neurostimulation

XANA is Swiss-Spanish Neurotechnological company that is developing a non-invasive Neurostimulation smart system, based on rigoruos scientific background, the lastest technologies and market applicability to create solid, realistic and scalable business models. XANA is bringing neurostimulation closer to the user around the world, with customized devices and personalized treatments, democratizing its use and improving customer experience. XANA`s pipeline is covering Medical Indications (postraumatic stress disorder & phobias, tinnitus, atrial fibrillation, attention-deficit-hyperactivity-disorde, ranxiety & depression, opioids withdrawal, chronic pain, epilepsy, migraine, obesity, ...) and Wellness Aplications. BODUS, our first product, is a clinically validated Vagus Nerve Stimulation system to enhance physical and cognitive performance as well as improve stress response. BODUS´ system is composed of miniaturized and wireless earbud, a native smartphone application and Arificial Intelligence Systems in cloud. BODUS´ earbud is customized to user´s ear anatomy to get the best efficiency, accuracy, usability and comfortability. Includes two big size electrodes (stimulation) and one biosensor (data collection). BODUS´ app easily manages and controls stimulation patters, charge, intensity, daily dose and shows benefits of BODUS and Vagus Nerve Stimulation. BODUS´ IA Systems will allow full personalized treatments per user profile, needs and activity as well as third parties (user´s Therapist, Coach or Trainer) intervention. BODUS is indicated for professional and amateur sports, corporate environment, intellectual activities and a full range of activities that requires improve physical recovery and selective attention, reduce time of reaction and stress response.

Company Metrics

  • Employees: 1-10
  • Monthly Visits: None
  • Tech Stack: None active products

Financial Information

  • Estimated Revenue: Less than $1M
  • Total Funding: 1130000 EUR
  • Last Funding: 420000 EUR (Seed)
  • Funding Status: Seed

Technology Stack

Xana Smart Neurostimulation actively uses None products in their tech stack.

Market Presence

Industries: Health Care, Health Diagnostics, Medical, Medical Device, Wellness

Headquarters: Epalinges, Vaud, Switzerland